Results of Pivotal Phase 2 Trial of SL-401 in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm
Results of Pivotal Phase 2 Trial of SL-401 in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm. EHA 2018. Oral Presentation
Results from Ongoing Phase 1/2 Trial of SL-401 in Patients with Intermediate or High Risk Relapsed/Refractory Myelofibrosis
Results from Ongoing Phase 1/2 Trial of SL-401 in Patients with Intermediate or High Risk Relapsed/Refractory Myelofibrosis. EHA 2018. Poster
Results from Ongoing Phase ½ Trial of SL-401 in Patients with Relapsed/Refractory CMML. EHA 2018.
Results from Ongoing Phase 1/2 Trial of SL-401 in Patients with Relapsed/Refractory CMML. EHA 2018. Poster